Syndromic male subfertility: A network view of genome–phenome associations-Reference-Cited by-同舟云学术

Syndromic male subfertility: A network view of genome–phenome associations

Published:2022-03-15 Issue:4 Volume:10 Page:720-732
ISSN:2047-2919
Container-title:Andrology
language:en
Short-container-title:Andrology

Author:

Mikec Špela¹,Kolenc Živa¹,Peterlin Borut²,Horvat Simon¹,Pogorevc Neža¹,Kunej Tanja¹^ORCID

Affiliation:

1. Department of Animal Science, Biotechnical Faculty University of Ljubljana Domžale Slovenia 1230

2. Clinical Institute for Genomic Medicine University Medical Center Ljubljana Šlajmerjeva 4 Ljubljana Slovenia 1000

Publisher

Wiley

Subject

Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/andr.13167

Reference92 articles.

1. Testing for genetic contributions to infertility: potential clinical impact

2. The Murine Testicular Transcriptome: Characterizing Gene Expression in the Testis During the Progression of Spermatogenesis1

3. Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis

4. RowePJ ComhaireFH HargreaveTB MahmoudAMA OrganizationWH.WHO manual for the standardized investigation diagnosis and management of the infertile male. Cambridge University Press.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gonadal dysfunction in a man with Noonan syndrome from the LZTR1 variant: case report and review of literature;Frontiers in Endocrinology;2024-04-16

2. Insight into the complexity of male infertility: a multi-omics review;Systems Biology in Reproductive Medicine;2024-03-22

3. Illuminating the terminal nerve: Uncovering the link between GnRH‐1 neuron and olfactory development;Journal of Comparative Neurology;2024-03

4. Illuminating the Terminal Nerve: Uncovering the Link between GnRH-1 and Olfactory Development;2023-09-03

5. Discovery of Drug-Responsive Phenomic Alteration-Related Driver Genes in the Treatment of Coronary Heart Disease;Pharmacogenomics and Personalized Medicine;2023-03